Ginkgo Bioworks Holdings Inc’s recently made public that its insider Dmytruk Mark E. unloaded Company’s shares for reported $53727.0 on Apr 02 ’24. In the deal valued at $1.05 per share,51,169 shares were sold. As a result of this transaction, Dmytruk Mark E. now holds 865,079 shares worth roughly $0.96 million.
Then, Dmytruk Mark E. sold 38,826 shares, generating $48,765 in total proceeds. Upon selling the shares at $1.26, the insider now owns 808,125 shares.
Before that, Dmytruk Mark E. sold 39,569 shares. Ginkgo Bioworks Holdings Inc shares valued at $47,799 were divested by the insider at a price of $1.21 per share. As a result of the transaction, Dmytruk Mark E. now holds 761,737 shares, worth roughly $0.85 million.
Raymond James downgraded its Ginkgo Bioworks Holdings Inc [DNA] rating to a Mkt perform from a an Outperform in a research note published on November 14, 2023; the price target was decreased to $2.50 from $3.50. A number of analysts have revised their coverage, including BTIG Research’s analysts, who decreased its forecast for the stock in early November from “a Buy” to “a Neutral”. Goldman also remained covering DNA and has decreased its forecast on June 02, 2023 with a “Sell” recommendation from previously “Neutral” rating. William Blair revised its rating on May 11, 2023. It rated DNA as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of DNA
On Monday, Ginkgo Bioworks Holdings Inc [NYSE:DNA] saw its stock jump 2.78% to $1.11. Over the last five days, the stock has lost -0.89%. Ginkgo Bioworks Holdings Inc shares have fallen nearly -34.32% since the year began. Nevertheless, the stocks have fallen -9.76% over the past one year. While a 52-week high of $2.55 was reached on 01/02/24, a 52-week low of $1.03 was recorded on 04/03/24. SMA at 50 days reached $1.2456, while 200 days put it at $1.5995. A total of 14.56 million shares were traded, compared to the trading of 17.01 million shares in the previous session.
Levels Of Support And Resistance For DNA Stock
The 24-hour chart illustrates a support level at 1.0800, which if violated will result in even more drops to 1.0500. On the upside, there is a resistance level at 1.1300. A further resistance level may holdings at 1.1500. The Relative Strength Index (RSI) on the 14-day chart is 45.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0126, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 52.94%. Stochastics %K at 33.33% indicates the stock is a holding.
How much short interest is there in Ginkgo Bioworks Holdings Inc?
A steep rise in short interest was recorded in Ginkgo Bioworks Holdings Inc stocks on Mar 15, 2024, growing by 12.01 million shares to a total of 262.24 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 250.23 million shares. There was a rise of 4.58%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 19.31% of the overall stock float, the days-to-cover ratio (short ratio) rose to 9.97.
The most recent change occurred on November 29, 2022 when Berenberg began covering the stock and recommended ‘”a Buy”‘ rating along with a $6 price target.
